Latest news
Faricimab in the Treatment of Retinal Disease: A Narrative Review - CureusCureus · Fri, 07 Aug 2026 06:26:24 GMTThe 180-day problem: How treatment nonadherence affects vision in nAMD | Eye Care Network - Modern Retina - Ophthalmology Times EuropeOphthalmology Times Europe · Thu, 06 Aug 2026 13:52:22 GMTReal-World Visual and Anatomic Outcomes With High-Dose Anti-VEGF Therapy in nAMD: Insights From the SPECTRUM Study (Episode 1 of 2) - Ophthalmology Times EuropeOphthalmology Times Europe · Fri, 31 Jul 2026 12:06:01 GMTAnti-VEGF/Ang-2 therapy shows fast drying in diabetic macular edema - HealioHealio · Wed, 29 Jul 2026 15:36:38 GMTAnti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD - The American Journal of Managed CareThe American Journal of Managed Care · Mon, 27 Jul 2026 15:12:06 GMTOutlook Therapeutics’ Recently Approved Therapy Could Become Preferred Anti-VEGF Treatment Option In $8.5B US Retina Market, Says BTIG - StocktwitsStocktwits · Mon, 27 Jul 2026 07:00:00 GMT